Andrew Sinclair - Net Worth and Insider Trading
Andrew Sinclair Net Worth
The estimated net worth of Andrew Sinclair is at least $102 Million dollars as of 2024-04-27. Andrew Sinclair is the Director of Sierra Oncology Inc and owns about 1,314,127 shares of Sierra Oncology Inc (SRRA) stock worth over $72 Million. Andrew Sinclair is the Director of Soleno Therapeutics Inc and owns about 686,840 shares of Soleno Therapeutics Inc (SLNO) stock worth over $26 Million. Andrew Sinclair is also the Director of Adicet Bio Inc and owns about 2,140,721 shares of Adicet Bio Inc (ACET) stock worth over $4 Million. Details can be seen in Andrew Sinclair's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Sinclair has not made any transactions after 2022-01-31 and currently still holds the listed stock(s).
Transaction Summary of Andrew Sinclair
Andrew Sinclair Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Sinclair owns 4 companies in total, including Soleno Therapeutics Inc (SLNO) , Sierra Oncology Inc (SRRA) , and Verona Pharma PLC (VRNA) among others .
Click here to see the complete history of Andrew Sinclair’s form 4 insider trades.
Insider Ownership Summary of Andrew Sinclair
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2020-06-26 | director |
| SRRA | Sierra Oncology Inc | 2022-01-31 | director |
| VRNA | Verona Pharma PLC | 2021-01-01 | director |
| ACET | Adicet Bio Inc | 2021-12-08 | director |
Andrew Sinclair Latest Holdings Summary
Andrew Sinclair currently owns a total of 3 stocks. Among these stocks, Andrew Sinclair owns 1,314,127 shares of Sierra Oncology Inc (SRRA) as of January 31, 2022, with a value of $72 Million and a weighting of 70.93%. Andrew Sinclair owns 686,840 shares of Soleno Therapeutics Inc (SLNO) as of June 26, 2020, with a value of $26 Million and a weighting of 25.54%. Andrew Sinclair also owns 2,140,721 shares of Adicet Bio Inc (ACET) as of December 8, 2021, with a value of $4 Million and a weighting of 3.53%.
Latest Holdings of Andrew Sinclair
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2022-01-31 | 1,314,127 | 54.99 | 72,263,844 |
| SLNO | Soleno Therapeutics Inc | 2020-06-26 | 686,840 | 37.89 | 26,024,368 |
| ACET | Adicet Bio Inc | 2021-12-08 | 2,140,721 | 1.68 | 3,596,411 |
Holding Weightings of Andrew Sinclair
Andrew Sinclair Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Sinclair has made a total of 1 transactions in Sierra Oncology Inc (SRRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sierra Oncology Inc is the acquisition of 150,000 shares on January 31, 2022, which cost Andrew Sinclair around $4 Million.
According to the SEC Form 4 filings, Andrew Sinclair has made a total of 2 transactions in Soleno Therapeutics Inc (SLNO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Soleno Therapeutics Inc is the acquisition of 222,222 shares on June 26, 2020, which cost Andrew Sinclair around $5 Million.
According to the SEC Form 4 filings, Andrew Sinclair has made a total of 2 transactions in Adicet Bio Inc (ACET) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Adicet Bio Inc is the acquisition of 500,000 shares on December 8, 2021, which cost Andrew Sinclair around $7 Million.
Insider Trading History of Andrew Sinclair
- 1
Andrew Sinclair Trading Performance
GuruFocus tracks the stock performance after each of Andrew Sinclair's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Sinclair is 48.8%. GuruFocus also compares Andrew Sinclair's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Sinclair within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Sinclair's insider trading performs compared to the benchmark.
Performance of Andrew Sinclair
Average Return
14.28%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.77 | 48.8 | 33 | 14.28 | -44.57 | -45.64 |
| Relative Return to S&P 500(%) | 3.99 | 47.84 | 30.18 | 2.52 | -56.27 | -60.88 |
Andrew Sinclair Ownership Network
Ownership Network List of Andrew Sinclair
Ownership Network Relation of Andrew Sinclair
Andrew Sinclair Owned Company Details
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Andrew Sinclair is the director of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include See Remarks Patricia C Hirano , See Remarks Kristen Yen , and director & See Remarks Bhatnagar Anish .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Andrew Sinclair made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net purchase of 1,210,087 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 196,136 shares made by Bhatnagar Anish , and a net sale of 52,057 shares made by Kristen Yen .
In summary, during the past 3 months, insiders sold 28,591 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 28,591 shares. During the past 18 months, 748,686 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net purchase of 461,401 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
Andrew Sinclair Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Sinclair. You might contact Andrew Sinclair via mailing address: C/o Soleno Therapeutics Inc., 1235 Radio Road, Suite 110, Redwood City Ca 94065.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
